Drug Shortages Explained

Eli discusses the complexities behind drug shortages, highlighting that manufacturers are only required to report interruptions in supply. The recent methotrexate shortage stems from manufacturing practice issues and shipping delays, with a significant portion of past shortages linked to quality problems. A representative from Accord emphasizes their efforts to improve quality and compliance, while a Brookings expert points out that market forces contribute to these ongoing challenges.